Not applicableStudy completedNCT02764554What this trial is testingPost-Marketing Surveillance of Lenvima in Korean PatientsWho this might be right forDifferentiated Thyroid Carcinoma (DTC) Eisai Korea Inc. 132
Large-scale testing (Phase 3)Study completedNCT00024427What this trial is testingTriacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic CancerWho this might be right forDrug/Agent Toxicity by Tissue/OrganPancreatic Cancer Wellstat Therapeutics 250
Testing effectiveness (Phase 2)Ended earlyNCT00319683What this trial is testingADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Adherex Technologies, Inc.
Large-scale testing (Phase 3)Study completedNCT00002870What this trial is testingHigh Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast CancerWho this might be right forBreast Cancer UNICANCER 180
Testing effectiveness (Phase 2)Study completedNCT01364493What this trial is testingEvaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric CancerWho this might be right forGastric Cancer Peking University 51
Early research (Phase 1)Study completedNCT03109249What this trial is testingPharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast CancerWho this might be right forRecurrent or Metastatic Breast Cancer Sun Pharma Advanced Research Company Limited 142
Large-scale testing (Phase 3)Ended earlyNCT02186301What this trial is testingTIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed TherapyWho this might be right forNon-Small Cell Lung Cancer Clovis Oncology, Inc. 100
Testing effectiveness (Phase 2)Study completedNCT00077129What this trial is testingPaclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell CancerWho this might be right forKidney Cancer Eastern Cooperative Oncology Group 22
Not applicableUnknownNCT05349045What this trial is testingAngiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal CancerWho this might be right forEsophageal Neoplasms The First Affiliated Hospital of Zhengzhou University 300
Large-scale testing (Phase 3)Study completedNCT00513539What this trial is testingBiliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by SurgeryWho this might be right forExtrahepatic Bile Duct CancerGallbladder Cancer University College, London 92
Not applicableEnrolling By InvitationNCT07683195What this trial is testingResearch on Early Recurrence of Locally Advanced Gastric Cancer Based on CT Radiomics PredictionWho this might be right forGastric Cancer Liu Yang 900
Early research (Phase 1)Active Not RecruitingNCT04360941What this trial is testingPAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast CancerWho this might be right forTriple Negative Breast CancerLocally Advanced Breast CancerRecurrent Breast Cancer+3 more Royal Marsden NHS Foundation Trust 45
Testing effectiveness (Phase 2)Looking for participantsNCT06042894What this trial is testingSI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast CancerWho this might be right forBreast Cancer Sichuan Baili Pharmaceutical Co., Ltd. 58
Large-scale testing (Phase 3)Temporarily pausedNCT02037529What this trial is testingEribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast CancerWho this might be right forBreast AdenocarcinomaHER2/Neu NegativeInvasive Breast Carcinoma+2 more Academic and Community Cancer Research United 201
Early research (Phase 1)Study completedNCT03761095What this trial is testingUnesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)Who this might be right forLeiomyosarcoma PTC Therapeutics 41
Testing effectiveness (Phase 2)Study completedNCT00390234What this trial is testingZiv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue SarcomaWho this might be right forFallopian Tube CancerFemale Reproductive CancerOvarian Carcinosarcoma+9 more National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)Study completedNCT00022698What this trial is testingCapecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal CancerWho this might be right forColorectal Cancer Hoffmann-La Roche 67
Testing effectiveness (Phase 2)Study completedNCT00111904What this trial is testingPaclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Theradex 43
Large-scale testing (Phase 3)Ended earlyNCT00113399What this trial is testingCombination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By SurgeryWho this might be right forHead and Neck Cancer Radiation Therapy Oncology Group 15
Large-scale testing (Phase 3)Active Not RecruitingNCT06519370What this trial is testingFDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast CancerWho this might be right forTriple Negative Breast Cancer Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 350